MDC Stock Overview
Medica S.p.A., together with its subsidiaries, designs, manufactures, and supplies medical products and hospital equipment in Italy and internationally.
Snowflake Score | |
---|---|
Valuation | 3/6 |
Future Growth | 4/6 |
Past Performance | 1/6 |
Financial Health | 4/6 |
Dividends | 0/6 |
Medica S.p.A. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | €19.40 |
52 Week High | €24.60 |
52 Week Low | €14.40 |
Beta | 0.22 |
1 Month Change | 19.75% |
3 Month Change | 28.48% |
1 Year Change | -11.01% |
3 Year Change | n/a |
5 Year Change | n/a |
Change since IPO | -42.00% |
Recent News & Updates
Risks To Shareholder Returns Are Elevated At These Prices For Medica S.p.A. (BIT:MDC)
Apr 06Returns On Capital Signal Tricky Times Ahead For Medica (BIT:MDC)
Feb 05Shareholder Returns
MDC | IT Medical Equipment | IT Market | |
---|---|---|---|
7D | 3.7% | -0.2% | -0.1% |
1Y | -11.0% | 5.2% | 17.3% |
Return vs Industry: MDC underperformed the Italian Medical Equipment industry which returned 5.2% over the past year.
Return vs Market: MDC underperformed the Italian Market which returned 17.3% over the past year.
Price Volatility
MDC volatility | |
---|---|
MDC Average Weekly Movement | 5.1% |
Medical Equipment Industry Average Movement | 4.2% |
Market Average Movement | 4.4% |
10% most volatile stocks in IT Market | 7.6% |
10% least volatile stocks in IT Market | 2.7% |
Stable Share Price: MDC has not had significant price volatility in the past 3 months.
Volatility Over Time: MDC's weekly volatility (5%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1985 | 676 | Marco Fecondini | www.medica.it |
Medica S.p.A., together with its subsidiaries, designs, manufactures, and supplies medical products and hospital equipment in Italy and internationally. It offers blood purification equipment comprising dialyzers, ultrafilters, HDF on line sets, blood lines, and pediatric dialyzers for dialysis treatment; and critical care CRRT equipment, hemofilters, pediatric filters, C02 removal, apheresis equipment, fractionator for cascade filtration, plasma filters, and leukocyte adsorber. The company also provides Cardiosmart, an integrated system for the treatment of patients affected by congestive heart failure; MediSulfone membrane and Purema hemoconcentrators for cardiosurgery; and VETSmart, a system to perform hemofiltration, dialysis, and plasmafiltration therapies; and ProtSmart.
Medica S.p.A. Fundamentals Summary
MDC fundamental statistics | |
---|---|
Market cap | €81.93m |
Earnings (TTM) | €2.97m |
Revenue (TTM) | €79.98m |
27.6x
P/E Ratio1.0x
P/S RatioIs MDC overvalued?
See Fair Value and valuation analysisEarnings & Revenue
MDC income statement (TTM) | |
---|---|
Revenue | €79.98m |
Cost of Revenue | €34.81m |
Gross Profit | €45.17m |
Other Expenses | €42.20m |
Earnings | €2.97m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
Earnings per share (EPS) | 0.70 |
Gross Margin | 56.47% |
Net Profit Margin | 3.71% |
Debt/Equity Ratio | 42.9% |
How did MDC perform over the long term?
See historical performance and comparison